Enterprise League logo

Product

NeuroQuantix Platform

BIOTECHNOLOGY

byCerebral Innovations

United States (US)

ABOUT THE PRODUCT

NeuroQuantix is a digitized spiral drawing assessment platform designed for clinical trial regulatory submission. It provides objective, quantitative motor endpoints across 23 neurological conditions, compliant with 21 CFR Part 11, EU GMP Annex 11, and GxP standards. The platform utilizes a deep kinematic library and iPad-based assessment for minimal site burden.

Information is owner-confirmed

Last updated 1 month ago

Price range
N/A

Other products/services from Cerebral Innovations